UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 585

Sortiert nach

P6 Practical comparison of GPT 3.5, Gemini and LLama 2 LLMs for structuring biomedical data from synthetic Finnish prostate cancer pathology statements

European urology open science (Online), 2024-05, Vol.63, p.S6-S6

2024

Volltextzugriff (PDF)

P12 Preliminary evidence of Gleason grade inflation in prostate cancer: A pre-treatment study

European urology open science (Online), 2024-05, Vol.63, p.S14-S14

2024

Volltextzugriff (PDF)

KeepEX, a simple dilution protocol for improving extracellular vesicle yields from urine

European journal of pharmaceutical sciences, 2017-02, Vol.98, p.30-39

2017

Volltextzugriff (PDF)

Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion

Oncogene, 2012-07, Vol.31 (29), p.3444-3456

2012

Volltextzugriff (PDF)

P11 Joint modelling to assess the relationship between time to curative treatment and treatment recurrence in Prostate Cancer patients

European urology open science (Online), 2024-05, Vol.63, p.S12-S13

2024

Volltextzugriff (PDF)

What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study

Prostate cancer and prostatic diseases, 2021-12, Vol.24 (4), p.1048-1054

2021

Volltextzugriff (PDF)

SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer

Scandinavian journal of urology, 2018-11, Vol.52 (5-6), p.313-320

2018

Volltextzugriff (PDF)

Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer

European urology open science (Online), 2022-07, Vol.41, p.63-73

2022

Volltextzugriff (PDF)

Infectious complications after MRI targeted vs systematic transrectal prostate biopsy

European urology open science (Online), 2020-07, Vol.19, p.e2314

2020

Volltextzugriff (PDF)

Precision systems medicine in urological Tumors – Molecular profiling and functional testing

ANNALS OF ONCOLOGY, 2017-10, Vol.28, p.vii2-vii2

2017

Volltextzugriff (PDF)

Does inclusion of MRI in active surveillance decrease the rate of discontinuation? A reflection of the use of MRI in the PRIAS study

European urology open science (Online), 2020-07, Vol.19, p.e1543-e1544

2020

Volltextzugriff (PDF)

Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013: a population-based analysis

Prostate cancer and prostatic diseases, 2016-12, Vol.19 (4), p.417-422

2016

Volltextzugriff (PDF)

Are confirmatory biopsies needed in patients on active surveillance who underwent upfront MRI with possible targeted biopsy?

European urology open science (Online), 2020-11, Vol.21, p.S88-S89

2020

Volltextzugriff (PDF)

273: Androgen receptor interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions

European journal of cancer (1990), 2014-07, Vol.50, p.S64-S64

2014

Volltextzugriff (PDF)

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

The Lancet (British edition), 2014-12, Vol.384 (9959), p.2027-2035

2014

Volltextzugriff (PDF)

A first step towards a global nomogram to predict disease progression for men on active surveillance

European urology open science (Online), 2020-07, Vol.19, p.e1905-e1906

2020

Volltextzugriff (PDF)

684: Helsinki Urological Biobank (HUB): A new-generation integrated biobank for facilitating precision medicine and translational research in urological cancers

European journal of cancer (1990), 2014-07, Vol.50, p.S164-S164

2014

Volltextzugriff (PDF)

Expected impact of MRI related interreader variability on ProScreen prostate cancer screening trial

European urology open science (Online), 2020-07, Vol.19, p.e166

2020

Volltextzugriff (PDF)

A high pretreatment plasma oestradiol level is associated with a low risk of acute myocardial infarction in parenteral oestrogen therapy for locally advanced prostate cancer

BJU international, 2008-05, Vol.101 (9), p.1090-1095

2008

Volltextzugriff (PDF)

Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation

Molecular human reproduction, 2002-04, Vol.8 (4), p.311-317

2002

Volltextzugriff (PDF)

P323 - PI-RADS score 5 is a strong predictor for rapid prostate cancer specific death

European urology, 2024-03, Vol.85, p.S446-S447

2024

Volltextzugriff (PDF)

PI-RADS score 5 is a strong predictor for rapid prostate cancer specific death

European urology, 2024-03, Vol.85, p.S446-S447

2024

Volltextzugriff (PDF)

Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes

Theranostics, 2017-01, Vol.7 (16), p.3824-3841

2017

Volltextzugriff (PDF)

Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

European urology, 2019-03, Vol.75 (3), p.523-531

2019

Volltextzugriff (PDF)

1 – 25 von 585

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(474)
Mit Volltextzugriff
(448)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

P6 Practical comparison of GPT 3.5, Gemini and LLama 2 LLMs for structuring biomedical data from synthetic Finnish prostate cancer pathology statements

P12 Preliminary evidence of Gleason grade inflation in prostate cancer: A pre-treatment study

KeepEX, a simple dilution protocol for improving extracellular vesicle yields from urine

Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion

P11 Joint modelling to assess the relationship between time to curative treatment and treatment recurrence in Prostate Cancer patients

What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study

SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer

Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer

Infectious complications after MRI targeted vs systematic transrectal prostate biopsy

Precision systems medicine in urological Tumors – Molecular profiling and functional testing

Does inclusion of MRI in active surveillance decrease the rate of discontinuation? A reflection of the use of MRI in the PRIAS study

Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013: a population-based analysis

Are confirmatory biopsies needed in patients on active surveillance who underwent upfront MRI with possible targeted biopsy?

273: Androgen receptor interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

A first step towards a global nomogram to predict disease progression for men on active surveillance

684: Helsinki Urological Biobank (HUB): A new-generation integrated biobank for facilitating precision medicine and translational research in urological cancers

Expected impact of MRI related interreader variability on ProScreen prostate cancer screening trial

A high pretreatment plasma oestradiol level is associated with a low risk of acute myocardial infarction in parenteral oestrogen therapy for locally advanced prostate cancer

Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation

P323 - PI-RADS score 5 is a strong predictor for rapid prostate cancer specific death

PI-RADS score 5 is a strong predictor for rapid prostate cancer specific death

Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes

Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

Suchergebnisse filtern